Posted On: 08/15/2016 8:10:22 AM
Post# of 23611

$ARTH ~ Arch Therapeutics Reports AC5 Topical Hemostatic Device Meets Primary and Secondary Endpoints in First Clinical Study
http://finance.yahoo.com/news/arch-therapeuti...00951.html
http://finance.yahoo.com/news/arch-therapeuti...00951.html

